# Evaluation of Clinical Effectiveness of Roflumilast in Routine Practice, in Chronic Obstructive Pulmonary Disease (COPD) Patients in Greece

> **NCT02187926** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 2577 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02187926
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 2577 (ACTUAL)
- **Last updated:** 2016-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02187926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02187926, "Evaluation of Clinical Effectiveness of Roflumilast in Routine Practice, in Chronic Obstructive Pulmonary Disease (COPD) Patients in Greece". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02187926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*